Inactive Instrument

JHL Biotech, Inc. Stock

6540

KYG7863U1076

Latest news about JHL Biotech, Inc.

Bora Pharmaceutical Laboratories Inc. acquired CDMO Assets of JHL Biotech, Inc. for $100 million.	22-05-09	CI
First Subjects Dosed in Australian Phase I Clinical Study of a Denosumab Biosimilar	20-05-18	CI
JHL Biotech, Inc. Announces First Patient Randomized in the Phase Iii Study of JHL1101 to Treat Diffuse Large B-Cell Lymphoma	18-12-27	CI
JHL Biotech, Inc. Announces China Approves Phase I and Phase III Clinical Trial Application for Bevacizumab Biosimilar to Treat Cancer	18-10-15	CI
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer	18-08-09	CI
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Rituximab Biosimilar	18-07-09	CI
Jhl Biotech Announces China Approves Clinical Trial Rituximab Biosimilar to Treat Non-Hodgkin Lymphoma	18-07-05	CI
JHL Biotech, Inc. Appoints Ellis Chu as Chief Financial Officer	18-06-13	CI
JHL Biotech, Inc. announced that it has received $106 million in funding from a group of investors	18-05-14	CI
JHL Biotech Seeks Financing	18-03-30	CI
JHL Biotech, Inc. Announces European Authority, Bulgarian Drug Agency Approves Phase I Clinical Trial Application	18-02-22	CI
JHL Biotech, Inc.(GTSM:6540) dropped from S&P Global BMI Index	18-02-12	CI
JHL Biotech, Inc.'s Board intends to launch an Equity Buyback.	18-02-05	CI
JHL Biotech, Inc. announced that it expects to receive $150 million in funding	18-01-15	CI
JHL Biotech, Inc. Submits Clinical Trial Application in Europe for Proposed Dornase Alfa Biosimilar to Affordably Manage Symptoms of Cystic Fibrosis	17-12-20	CI

More news

Managers and Directors - JHL Biotech, Inc.

Managers	Title	Age	Since
Raco Ivan Jordanov CEO	Chief Executive Officer	76	12-06-11
Ellis Chu DFI	Director of Finance/CFO	-	18-04-30
Cui WeiDong CTO	Chief Tech/Sci/R&D Officer	-	-

Members of the board	Title	Age	Since
Zuie Chin Huang CHM	Chairman	58	12-12-16
Bryant Fong BRD	Director/Board Member	51	12-12-16
Yi Hsiung Chen BRD	Director/Board Member	-	15-05-13

More insiders

JHL BIOTECH, INC. is a Taiwan-based company principally engaged in development and manufacturing of biopharmaceuticals. The Company provides cell line cloning, process development, and manufacturing capabilities and services to emerging and established biopharmaceutical companies seeking to collaboratively develop, manufacture and commercialize biologics.

Sector

Pharmaceuticals

More about the company

Sector Biopharmaceuticals

	1st Jan change	Capi.
CSL LIMITED	-4.66%	87.53B
SAMSUNG BIOLOGICS CO.,LTD.	+1.32%	40.42B
BIOGEN INC.	-19.27%	29.48B
UCB	+57.86%	25.43B
INCYTE CORPORATION	-17.69%	11.49B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.00%	11.3B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.14%	11.1B
SWEDISH ORPHAN BIOVITRUM AB	+5.24%	8.75B
INNOVENT BIOLOGICS, INC.	-8.42%	7.99B

Biopharmaceuticals